Continuous Flow Left Ventricular Assist Device Improves Functional Capacity and Quality of Life of Advanced Heart Failure Patients

Joseph G. Rogers(Baylor College of Medicine), Mark S. Slaughter(University of Louisville), Francis D. Pagani(Michigan Medicine), Stuart D. Russell(Duke Medical Center), Carmelo A. Milano(Duke University Hospital), Ranjit John(University of Minnesota), Keith D. Aaronson(University of Michigan), Andrew Boyle(Thomas Jefferson University), David J. Farrar(JTEC Corporation (Japan)), Brooks S. Edwards(Mayo Clinic), John V. Conte(Commonwealth Medical College), Soon Park(Mayo Clinic)
Journal of the American College of Cardiology
April 1, 2010
10.1016/j.jacc.2009.12.052
Cited by 583

Related Papers

Valvular Heart Disease Associated with Fenfluramine–Phentermine
|New England Journal of Medicine|1997|1.6k
Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial
|The Lancet|2020|1k
Clinical management of continuous-flow left ventricular assist devices in advanced heart failure
|The Journal of Heart and Lung Transplantation|2010|876
Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure
|New England Journal of Medicine|2017|757
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711